Does CEFTAROLINE Cause Agranulocytosis? 12 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Agranulocytosis have been filed in association with CEFTAROLINE. This represents 3.7% of all adverse event reports for CEFTAROLINE.
12
Reports of Agranulocytosis with CEFTAROLINE
3.7%
of all CEFTAROLINE reports
0
Deaths
11
Hospitalizations
How Dangerous Is Agranulocytosis From CEFTAROLINE?
Of the 12 reports, 11 (91.7%) required hospitalization, and 3 (25.0%) were considered life-threatening.
Is Agranulocytosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CEFTAROLINE. However, 12 reports have been filed with the FAERS database.
What Other Side Effects Does CEFTAROLINE Cause?
Drug ineffective (70)
Acute kidney injury (39)
Off label use (33)
Toxic epidermal necrolysis (27)
Thrombocytopenia (22)
Treatment failure (22)
Neutropenia (18)
Pyrexia (18)
Rash (18)
Drug reaction with eosinophilia and systemic symptoms (17)
What Other Drugs Cause Agranulocytosis?
CLOZAPINE (1,766)
CYCLOPHOSPHAMIDE (1,242)
RITUXIMAB (1,154)
SULFAMETHOXAZOLE\TRIMETHOPRIM (797)
PANTOPRAZOLE (599)
METHOTREXATE (550)
SODIUM (549)
EPIRUBICIN (491)
METAMIZOLE (438)
DOCETAXEL (436)
Which CEFTAROLINE Alternatives Have Lower Agranulocytosis Risk?
CEFTAROLINE vs CEFTAROLINE FOSAMIL
CEFTAROLINE vs CEFTAZIDIME
CEFTAROLINE vs CEFTIBUTEN
CEFTAROLINE vs CEFTOLOZANE\TAZOBACTAM
CEFTAROLINE vs CEFTRIAXONE